Stifel Financial Corp Has $72,000 Position in Definitive Healthcare Corp. (NASDAQ:DH)

Stifel Financial Corp lessened its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 72.4% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 16,039 shares of the company’s stock after selling 42,094 shares during the quarter. Stifel Financial Corp’s holdings in Definitive Healthcare were worth $72,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Millennium Management LLC acquired a new position in Definitive Healthcare in the 2nd quarter valued at $9,283,000. Massachusetts Financial Services Co. MA increased its stake in shares of Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after purchasing an additional 1,626,813 shares during the last quarter. 272 Capital LP bought a new position in Definitive Healthcare in the 2nd quarter valued at approximately $3,480,000. Marshall Wace LLP acquired a new position in Definitive Healthcare in the 2nd quarter worth about $1,535,000. Finally, Algert Global LLC acquired a new position in shares of Definitive Healthcare during the second quarter worth $1,265,000. Institutional investors own 98.67% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on DH shares. Stephens began coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. BTIG Research began coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target for the company. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $5.72.

Insider Buying and Selling at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 14.84% of the stock is currently owned by company insiders.

Definitive Healthcare Stock Performance

NASDAQ DH opened at $4.11 on Tuesday. The stock has a market capitalization of $474.80 million, a PE ratio of -1.33, a P/E/G ratio of 3.29 and a beta of 1.40. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The company’s 50 day simple moving average is $4.38 and its two-hundred day simple moving average is $4.61. Definitive Healthcare Corp. has a 1 year low of $3.19 and a 1 year high of $10.62.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.